Please select the option that best describes you:
In patients with localized small cell bladder cancer, would you consider consolidation with durvalumab after neoadjuvant chemotherapy followed by definitive local therapy (cystectomy or RT)?
Extrapolating from the ADRIATIC study in limited-stage SCLC.
Would your opinion change based on local therapy (cystectomy vs RT)?